President Biden's new executive order, which includes $200 million for research at the National Institutes of Health, directs federal agencies to explore ways to develop new resources to guide women on prevention and treatment.
During a recent EBRI-Milken Institute 2024 Retirement Symposium panel, a group of industry thought leaders discussed financial wellness and what it means employers and advisors.
An investigation was launched on Tuesday into the PBGC, which a House Committee alleges it failed to stop funds from going to deceased plan participants, even though the PBGC asserts that the funds were not "improperly" paid.
The White House is cracking down on drugmakers that have raised the costs of their medications faster that the rate of inflation – another move in a series of price-fighting measures being rolled out under the Inflation Reduction Act.
Health care leaders urged Congress at a hearing to pass regulations on the use of artificial intelligence in the industry, addressing the "limitless" capabilities of the new technology as well as the potential biases it can produce.